Skip to main content

and
  1. Article

    Open Access

    Intravaginal lactic acid gel versus oral metronidazole for treating women with recurrent bacterial vaginosis: the VITA randomised controlled trial

    Bacterial vaginosis is a common and distressing condition for women. Short-term antibiotic treatment is usually clinically effective, but recurrence is common. We assessed the effectiveness of intravaginal lac...

    Jonathan D. C. Ross, Clare Brittain, Jocelyn Anstey Watkins, Joe Kai in BMC Women's Health (2023)

  2. Article

    Open Access

    Metronidazole versus lactic acid for treating bacterial vaginosis (VITA): protocol for a randomised controlled trial to assess the clinical and cost effectiveness of topical lactic acid gel for treating second and subsequent episodes of bacterial vaginosis

    Bacterial vaginosis (BV) affects 30–50% of women at some time in their lives and is an embarrassing and distressing condition which can be associated with potentially serious comorbidities. Current antibiotic ...

    Lindsay Armstrong-Buisseret, Clare Brittain, Miruna David, Gillian Dean in Trials (2019)